190 related articles for article (PubMed ID: 10385662)
1. Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European Concerted Action on Viral Hepatitis (EUROHEP).
Janssen HL; Gerken G; Carreño V; Marcellin P; Naoumov NV; Craxi A; Ring-Larsen H; Kitis G; van Hattum J; de Vries RA; Michielsen PP; ten Kate FJ; Hop WC; Heijtink RA; Honkoop P; Schalm SW
Hepatology; 1999 Jul; 30(1):238-43. PubMed ID: 10385662
[TBL] [Abstract][Full Text] [Related]
2. Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a. The European Concerted Action on Viral Hepatitis (EUROHEP).
Carreño V; Marcellin P; Hadziyannis S; Salmerón J; Diago M; Kitis GE; Vafiadis I; Schalm SW; Zahm F; Manzarbeitia F; Jiménez FJ; Quiroga JA
Hepatology; 1999 Jul; 30(1):277-82. PubMed ID: 10385667
[TBL] [Abstract][Full Text] [Related]
3. Interferon alpha-2b with and without ribavirin in the treatment of hepatitis B e antigen-positive chronic hepatitis B: a randomized study.
Liu CJ; Lai MY; Chao YC; Liao LY; Yang SS; Hsiao TJ; Hsieh TY; Lin CL; Hu JT; Chen CL; Chen PJ; Kao JH; Chen DS
Hepatology; 2006 Apr; 43(4):742-9. PubMed ID: 16557544
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody--and hepatitis B virus DNA--positive chronic hepatitis B.
Andreone P; Cursaro C; Gramenzi A; Zavagliz C; Rezakovic I; Altomare E; Severini R; Franzone JS; Albano O; Ideo G; Bernardi M; Gasbarrini G
Hepatology; 1996 Oct; 24(4):774-7. PubMed ID: 8855175
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B: a randomized controlled study.
You J; Zhuang L; Cheng HY; Yan SM; Yu L; Huang JH; Tang BZ; Huang ML; Ma YL; Chongsuvivatwong V; Sriplung H; Geater A; Qiao YW; Wu RX
World J Gastroenterol; 2006 Nov; 12(41):6715-21. PubMed ID: 17075991
[TBL] [Abstract][Full Text] [Related]
6. A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum.
Lampertico P; Del Ninno E; Manzin A; Donato MF; Rumi MG; Lunghi G; Morabito A; Clementi M; Colombo M
Hepatology; 1997 Dec; 26(6):1621-5. PubMed ID: 9398007
[TBL] [Abstract][Full Text] [Related]
7. Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial.
Chung YH; Song BC; Lee GC; Shin JW; Ryu SH; Jung SA; Yoo K; Lee HC; Lee YS; Suh DJ
Eur J Gastroenterol Hepatol; 2003 May; 15(5):489-93. PubMed ID: 12702905
[TBL] [Abstract][Full Text] [Related]
8. Treatment of HBeAg positive chronic hepatitis B: interferon or nucleoside analogues.
Dusheiko G
Liver Int; 2013 Feb; 33 Suppl 1():137-50. PubMed ID: 23286858
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.
Sakai T; Shiraki K; Inoue H; Okano H; Deguchi M; Sugimoto K; Ohmori S; Murata K; Nakano T
Int J Mol Med; 2002 Aug; 10(2):201-4. PubMed ID: 12119559
[TBL] [Abstract][Full Text] [Related]
10. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
[TBL] [Abstract][Full Text] [Related]
11. Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alpha.
van der Eijk AA; Niesters HG; Hansen BE; Heijtink RA; Janssen HL; Schalm SW; de Man RA
J Viral Hepat; 2006 Feb; 13(2):96-103. PubMed ID: 16436127
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of changes in serum hepatitis B virus DNA titer in patients with chronic hepatitis B treated with interferon.
Hwang SJ; Lu RH; Wang YJ; Chu CW; Wu JC; Chang FY; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jan; 63(1):1-7. PubMed ID: 10645044
[TBL] [Abstract][Full Text] [Related]
13. [Quantitative detection of intrahepatic hepatitis B virus DNA in patients with chronic hepatitis B].
Lu H; Ma LX; Xu WS; Zhang HY; Yu LJ; Duan HY
Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):173-5. PubMed ID: 12681068
[TBL] [Abstract][Full Text] [Related]
14. Comparison of 12-month courses of interferon-alpha-2b-lamivudine combination therapy and interferon-alpha-2b monotherapy among patients with untreated chronic hepatitis B.
Yalcin K; Degertekin H; Yildiz F; Celik Y
Clin Infect Dis; 2003 Jun; 36(12):1516-22. PubMed ID: 12802750
[TBL] [Abstract][Full Text] [Related]
15. HBV-DNA level in blood serum as a predictor of good response to therapy with interferon-alpha-2b of patients with chronic hepatitis B.
Simon K; Rotter K; Zalewska M; Gładysz A
Med Sci Monit; 2000; 6(5):971-5. PubMed ID: 11208440
[TBL] [Abstract][Full Text] [Related]
16. Interferon-alpha therapy in chronic hepatitis B: early monitoring of hepatitis B e antigen may help to decide whether to stop or to prolong therapy.
Heijtink RA; Janssen HL; Hop WC; Osterhaus AD; Schalm SW
J Viral Hepat; 2000 Sep; 7(5):382-6. PubMed ID: 10971827
[TBL] [Abstract][Full Text] [Related]
17. Natural history of chronic hepatitis B virus infection in childhood and efficacy of interferon therapy.
Takano T; Tajiri H; Etani Y; Miyoshi Y; Tanaka Y; Brooks S
Scand J Gastroenterol; 2015 Jul; 50(7):892-9. PubMed ID: 25861806
[TBL] [Abstract][Full Text] [Related]
18. [Effect of interferon-alpha treatment in children with hepatitis B e antigen-positive chronic hepatitis B virus infection: a meta-analysis of follow-up for six months to two years].
Lin ZQ; Fang F; Guo ZF; Chen Q
Zhonghua Er Ke Za Zhi; 2007 Aug; 45(8):592-8. PubMed ID: 18021533
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.
Yuen MF; Hui CK; Cheng CC; Wu CH; Lai YP; Lai CL
Hepatology; 2001 Jul; 34(1):139-45. PubMed ID: 11431745
[TBL] [Abstract][Full Text] [Related]
20. Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: results of a pilot study.
Serfaty L; Thabut D; Zoulim F; Andreani T; Chazouillères O; Carbonell N; Loria A; Poupon R
Hepatology; 2001 Sep; 34(3):573-7. PubMed ID: 11526544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
